Browsing Tag

Therapy

14 posts
Radioligand Therapy Continues to Show Promise for Metastatic CRPC thumbnail

Radioligand Therapy Continues to Show Promise for Metastatic CRPC

Oncology/Hematology > Prostate Cancer — Median OS of 15.5 months, PFS of 7.9 months with Ac-225-PSMA in heavily treated patients by Charles Bankhead, Senior Editor, MedPage Today February 16, 2024 Radioligand therapy (RLT) with actinium-225 targeting prostate-specific membrane antigen (225Ac-PSMA) had a "substantial antitumor effect" in heavily pretreated metastatic castration-resistant prostate cancer (mCRPC), a large
Read More
New digital therapy reduces anxiety and depression in people living with long-term physical health conditions thumbnail

New digital therapy reduces anxiety and depression in people living with long-term physical health conditions

Credit: Pixabay/CC0 Public Domain A therapist-guided digital cognitive behavioral therapy reduced distress in 89% of participants living with long-term physical health conditions, a new King's College London study finds. The findings appear in Psychological Medicine. Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London found that people living with long-term
Read More
Proton beam therapy thumbnail

Proton beam therapy

Vivien Williams: Standard radiation therapy is an effective way to treat many cancers but it isn't perfect. It kills cancer cells but it also kills healthy cells in its path through the body. That is just one of the reasons Mayo Clinic is bringing a new type of radiation therapy to its patients. It's called
Read More
Gene Therapy Offers New Way to Fight Alcohol Use Disorder thumbnail

Gene Therapy Offers New Way to Fight Alcohol Use Disorder

Please enable cookies. Error 1005 Ray ID: 816d18ff3dc08a02 • 2023-10-16 03:08:29 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 816d18ff3dc08a02 • Your IP: 89.117.245.16 •
Read More
CAR-T Therapy Effective in Youngest Kids With ALL thumbnail

CAR-T Therapy Effective in Youngest Kids With ALL

The use of tisagenlecleucel (Kymriah) in children younger than 3 years of age with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) was as effective, and safe, in a retrospective cohort study as it was previously seen to be for older children in the ELIANA trial. In an analysis of 38 patients – most of
Read More
New therapy breakthrough changes the shape of treatment for undruggable diseases thumbnail

New therapy breakthrough changes the shape of treatment for undruggable diseases

DUBTACs are heterobifunctional molecules consisting of a protein-targeting ligand linked to a DUB recruiter via a linker. DUBTACs are ideally used for stabilizing the levels of actively ubiquitinated proteins that are degraded by the proteasome. Credit: Nomura Lab For some time, scientists have been working on the major challenge of developing new therapies against many…
Read More
HIV: Dual Therapy With Twice-Yearly Injections on the Horizon thumbnail

HIV: Dual Therapy With Twice-Yearly Injections on the Horizon

One year into treatment with an every-6-month dose of the investigational drug lenacapavir (LEN, Gilead Sciences) in a dual-treatment combination, 88% of treatment-naive people living with HIV had undetectable viral loads. The findings, presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2022 Annual Meeting, also showed the drug was well tolerated, with 2…
Read More
Gene Therapy Shows Clinical Benefit in Metachromatic Leukodystrophy thumbnail

Gene Therapy Shows Clinical Benefit in Metachromatic Leukodystrophy

An investigational gene therapy showed benefit in pediatric patients with early-onset metachromatic leukodystrophy (MLD), a small study showed. Treatment with atidarsagene autotemcel (arsa-cel) preserved motor development and cognitive function in MLD patients enrolled in a prospective phase I/II trial or treated through expanded access programs, reported Alessandro Aiuti, MD, of the San Raffaele Telethon Institute…
Read More
Index Of News